EnBio Holdings, Inc
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from EnBio Holdings, Inc's yearly results (2023–2026), compared with Industrials companies in Japan. Tap ? on any ratio for what it means.
What stands out
- Shareholder Slice Ratio: Share count rose 22% in 3 years, so each share's slice of the company became smaller. Dividends paid equalled 13% of profit over the same period. Bigger rise in share count than 98% of Industrials companies in Japan.
- Growth Efficiency Ratio: Sales grew 56% in 3 years, but profit fell: ¥12 less profit per ¥100 of extra sales. Lower than 92% of Industrials companies in Japan.
- Cash Cushion Ratio: Debt, after subtracting cash, is 1.0 times its market value (net debt). Lower than 92% of Industrials companies in Japan.
Where ¥100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
¥200Over the last 3 years, every ¥100 of reported profit came with ¥200 of operating cash.
Higher than 83% of Industrials companies in Japan.
Self-Funding Ratio
0.8×Over the last 3 years its own operating cash paid for 79% of its investment spending (capex); the rest came from other sources such as borrowing, cash reserves or new shares.
Lower than 82% of Industrials companies in Japan.
Cash Locked Ratio
¥40For every ¥100 of sales, ¥40 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ¥43 tied up three years earlier.
More money tied up than 81% of Industrials companies in Japan.
Growth quality
Steadiness Ratio
3/3 · 0/3Sales grew in 3 of the last 3 years; profit grew in 0 of 3.
Less steady than 79% of Industrials companies in Japan.
Growth Efficiency Ratio
−¥12Sales grew 56% in 3 years, but profit fell: ¥12 less profit per ¥100 of extra sales.
Lower than 92% of Industrials companies in Japan.
Asset Productivity Ratio
+56% / +32%In 3 years sales changed by +56% while total assets changed by +32%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
0.4×Debt due within a year is covered 0.4 times by its yearly operating cash.
Lower than 73% of Industrials companies in Japan.
Cash Cushion Ratio
1.0× debtDebt, after subtracting cash, is 1.0 times its market value (net debt).
Lower than 92% of Industrials companies in Japan.
Tangible Assets Ratio
98%Of every ¥100 the company owns, ¥98 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 60% of Industrials companies in Japan.
Tangible Net Worth Ratio
95%Of every ¥100 of net worth, ¥95 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 64% of Industrials companies in Japan.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
EnBio Holdings, Inc owes ¥0.57 for every ¥1 it owns. Net profit fell 41% in the year to Mar 2026, and shrank 31% a year on average over 3 years.
Compared with Industrials companies in Japan · latest annual results Mar 2026.
P/E ratio
11.5Investors pay ¥11.5 for every ¥1 of EnBio Holdings, Inc's yearly profit, lower than 59% of Industrials companies in Japan.
P/B ratio
0.67The share price is 0.67 times EnBio Holdings, Inc's book value per share, lower than 78% of Industrials companies in Japan.
Market cap
¥6.3 BThe total market value of all of EnBio Holdings, Inc's shares at today's price (share price × number of shares), smaller than 79% of Industrials companies in Japan. PosiCap size class: Micro Cap.
Net worth (book value)
¥9.5 BWhat EnBio Holdings, Inc would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥1,167Net worth divided by the number of shares. The share price of ¥780.00 is 0.7 times this, which is the P/B above.
Return on equity (ROE)
5.8%EnBio Holdings, Inc earned 5.8% on its shareholders' money over the last year, lower than 72% of Industrials companies in Japan.
Owes vs Owns
0.57×EnBio Holdings, Inc owes ¥0.57 for every ¥1 it owns (moderate), higher than 78% of Industrials companies in Japan.
Dividend yield
3.05%EnBio Holdings, Inc pays 3.05% of its share price as dividends a year, lower than 52% of dividend-paying Industrials companies in Japan.
Revenue growth
+18%Revenue rose 18% in the year to Mar 2026, and grew 16% a year on average over 3 years.
Profit growth
-41%Net profit fell 41% in the year to Mar 2026, and shrank 31% a year on average over 3 years.
Profit margin
2.1%EnBio Holdings, Inc keeps ¥2 of every ¥100 of revenue as net profit.
Cash quality
4.4×Cash from EnBio Holdings, Inc's business was 4.4× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
9.0×EnBio Holdings, Inc's operating profit covered its interest costs 9.0 times in the year to Mar 2026.
Cash vs debt
Net debtEnBio Holdings, Inc had ¥6.6 B more debt than cash (net debt) at Mar 2026.
Questions
What is EnBio Holdings, Inc's P/E ratio?
Investors pay ¥11.5 for every ¥1 of EnBio Holdings, Inc's yearly profit, lower than 59% of Industrials companies in Japan.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For EnBio Holdings, Inc: ¥6.3 B ÷ ¥9.5 B (30 Jun 2026) = 0.7.
What is EnBio Holdings, Inc's return on equity?
EnBio Holdings, Inc earned 5.8% on its shareholders' money over the last year, lower than 72% of Industrials companies in Japan.
How much does EnBio Holdings, Inc owe compared with what it owns?
EnBio Holdings, Inc owes ¥0.57 for every ¥1 it owns (moderate), higher than 78% of Industrials companies in Japan.
Does EnBio Holdings, Inc pay a dividend?
Yes. EnBio Holdings, Inc pays 3.05% of its share price as dividends a year, lower than 52% of dividend-paying Industrials companies in Japan.
Is EnBio Holdings, Inc's revenue growing?
Revenue rose 18% in the year to Mar 2026, and grew 16% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.